Cargando…

Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy

To assess the applicability of perfusion-weighted (PWI) magnetic resonance (MR) imaging in clinical practice, as well as to evaluate the changes in PWI in brain metastases before and after stereotactic radiotherapy (SRT), and to correlate these changes to tumor status on conventional MR imaging. Ser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kerkhof, M., Ganeff, I., Wiggenraad, R. G. J., Lycklama à Nijeholt, G. J., Hammer, S., Taphoorn, M. J. B., Dirven, L., Vos, M. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928168/ https://www.ncbi.nlm.nih.gov/pubmed/29392588 http://dx.doi.org/10.1007/s11060-018-2779-7

Ejemplares similares

Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy
por: van der Meer, Pim B., et al.
Publicado: (2018)

SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases
por: Crouzen, J. A., et al.
Publicado: (2023)

SMART syndrome: a late reversible complication after radiation therapy for brain tumours
por: Kerklaan, Joost P., et al.
Publicado: (2011)

Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013)

An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases
por: Ding, Shouliang, et al.
Publicado: (2023)

Impact of PTV margin reduction (2 mm to 0 mm) on pseudoprogression in stereotactic radiotherapy of solitary brain metastases
por: Badloe, Justine, et al.
Publicado: (2021)

MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial
por: Hoegen, P., et al.
Publicado: (2022)

A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases
por: Hartgerink, Dianne, et al.
Publicado: (2021)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
por: Gutschenritter, Tyler, et al.
Publicado: (2020)

Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and Radiotherapy
por: Zwingenberger, A.L., et al.
Publicado: (2016)

Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy
por: Detsky, Jay S., et al.
Publicado: (2018)

A novel approach for dose painting radiotherapy of brain metastases guided by mr perfusion images
por: Hou, Chuanke, et al.
Publicado: (2022)

Stereotactic MR-Guided Radiotherapy for Adrenal Gland Metastases: First Clinical Results
por: Michalet, Morgan, et al.
Publicado: (2022)

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
por: Zindler, Jaap D., et al.
Publicado: (2017)

Quality of Automated Stereotactic Radiosurgery Plans in Patients with 4 to 10 Brain Metastases
por: Petoukhova, Anna, et al.
Publicado: (2021)

Health-related quality of life of patients with brain metastases selected for stereotactic radiosurgery
por: Verhaak, Eline, et al.
Publicado: (2019)

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
por: Calderon, Benoît, et al.
Publicado: (2023)

RONC-06. Stereotactic radiosurgery and stereotactic radiotherapy for pediatric brain metastases or recurrences
por: McGovern, Susan, et al.
Publicado: (2022)

Perfusion MRI in the evaluation of brain metastases: current practice review and rationale for study of baseline MR perfusion imaging prior to stereotactic radiosurgery (STARBEAM-X)
por: Dobeson, Caroline Beverley, et al.
Publicado: (2023)

Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases
por: Weykamp, Fabian, et al.
Publicado: (2023)

Spine Stereotactic Body Radiotherapy Outcomes in Patients with Concurrent Brain Metastases
por: Colaco, Rovel J, et al.
Publicado: (2016)

Dynamic susceptibility MR perfusion in diagnosing recurrent brain metastases after radiotherapy: A systematic review and meta‐analysis
por: Kwee, Robert M., et al.
Publicado: (2019)

Non Tumor Perfusion Changes Following Stereotactic Radiosurgery to Brain Metastases
por: Jakubovic, Raphael, et al.
Publicado: (2015)

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study
por: Kerkhof, M., et al.
Publicado: (2019)

Cognitive functioning and predictors thereof in patients with 1–10 brain metastases selected for stereotactic radiosurgery
por: Schimmel, Wietske C. M., et al.
Publicado: (2019)

Stereotactic radiotherapy on brain metastases with recent hemorrhagic signal: STEREO-HBM, a two-step phase 2 trial
por: Lesueur, Paul, et al.
Publicado: (2020)

Stereotactic radiotherapy in epithelial ovarian cancer brain metastases patients
por: Celejewska, Agata, et al.
Publicado: (2014)

Neuroendocrine Carcinoma of Uterine Cervix: Stereotactic Radiotherapy for Brain Metastasis and Stereotactic Body Radiotherapy for Renal and Pancreatic Metastases
por: Mori, Yoshimasa, et al.
Publicado: (2020)

Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac – Feasibility, workflow data and patient acceptance
por: Gani, Cihan, et al.
Publicado: (2020)

Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases
por: Combs, Stephanie E., et al.
Publicado: (2018)

Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study
por: Bordeau, Karl, et al.
Publicado: (2023)

Development of a questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumors: a pilot study
por: Oort, Q., et al.
Publicado: (2017)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
por: Xie, Xue-Yi, et al.
Publicado: (2022)

Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiosurgery (SRS) to the resection cavity of brain metastases after surgical resection (SATURNUS): study protocol for a randomized phase III trial
por: Waltenberger, Maria, et al.
Publicado: (2023)

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
por: van Dorp, Martijn, et al.
Publicado: (2023)

eHealth cognitive rehabilitation for brain tumor patients: results of a randomized controlled trial
por: van der Linden, Sophie D., et al.
Publicado: (2021)

The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review
por: van Opijnen, Mark P., et al.
Publicado: (2019)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
por: Jiang, Xue-song, et al.
Publicado: (2012)

Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases
por: Ingrosso, Gianluca, et al.
Publicado: (2012)

Five-Fraction Stereotactic Radiotherapy for Brain Metastases—A Retrospective Analysis
por: Layer, Julian P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bv2b6q14acsfv9e4jhffc7fdig